This is especially true for rituximab, a chimeric monoclonal antibody targeting the CD20 antigen found on both normal B cells and on most low-grade and some high grade B-cell lymphomas [93]

This is especially true for rituximab, a chimeric monoclonal antibody targeting the CD20 antigen found on both normal B cells and on most low-grade and some high grade B-cell lymphomas [93]. revised, highlighting the situations where this strategy has proven to be successful and eventual clues to obtain better results in the future. == 1. Intro == Tumors are in long term state of chronic swelling, and lymphoproliferative syndromes are not only a collection of tumoral cells or a simple genetic disease. Tumoral cells may give and receive instructions from additional structural parts, the tumor microenvironment, which is composed by extracellular matrix, stromal cells, neoangiogenic vessels and overall, the cells and cytokines that constitute the tumoral immune response. These elements constitute a complex signalling network where a delicate balance is present between microenvironment and tumoral cells. The products of mutated or deregulated genes contribute to the growth and invasion of tumoral cells, as well as to the manifestation of proteins with the ability to stimulate the immune response. The immunogenic capacity of the tumor can be evaluated AMG 579 by means of the study of the reactive infiltration, which is mainly made up by innate immune cells, especially macrophages, also granulocytes, eosinophils and mast cells, and adaptive immune cells, especially cytotoxic T cellsCTLs-, the most important suppressor of tumoral growth and target for vaccine methods. The hypothesis of immunesurveillance postulates that one of the principal functions of the immune system would be realizing neoplastic cells and removing them before they form tumors [1]. This affirmation implies that in the absence of an effective immune system there is a high risk of developing cancer. Truly, there is evidence involving the immune system in the safety from particular tumors, especially those associated with viral infections, tumors related with seniors, transplanted and immunosuppressed AMG 579 individuals, and those lymphomas associated with Epstein-Barr disease (EBV), Kaposi’s sarcoma, and human being immunodeficiency disease (HIV). Immune system is a nonlinear complex system, and its main function in cancer is acting as an effective suppressive system of tumors. However, as it happens in the immunology of infectious diseases, an adequate defense response with enough magnitude to eradicate the microorganism or harmful pathogen is necessary. However, the system can behave in an ineffective manner, as the appearance of tumors in immunocompetent populace shows. So, along with the concept of immunosurveillance as immune defensive process, the concept of immunostimulation also occurs [2], meaning that the immune response might not only be ineffective but it might contribute actively to tumoral progression. Among different molecular AMG 579 unique alterations of the lymphoproliferative syndromes, the part of the microenvironment has been studied extensively, and lymphocytes (cytotoxic T cellsCTL- and native killerNK-), macrophages, dendritic cells, and neutrophils constitute potential effectors of the antitumoral immunity. However, in the last few years a huge amount of evidence has emerged suggesting that these cells can also promote the growth and the development of the neoplasia, and that the immune system not only can affect the tumor, but the tumor itself may also alter the sponsor immune ARVD system. The ability of the immune system to act like a double-edge weapon, protective or revitalizing, shows that tumoral clearance requires the effective coordination of the different elements of the immune system in an appropriate balance in amount and quality. Consequently, current cancer study in lymphoproliferative syndromes along with other tumors is designed to develop techniques to increase the performance of sponsor antitumor immune response. This inevitably leads to consider tumors as more than an accumulation of neoplastic cells; they might be more properly considered as a functional cells immunologically mediated and created by a complex tissue network in which neoangiogenesis, infiltrating immune competent cells, stromal cells, and a differentiated and specific extracellular matrix constitute the tumor microenvironment with the capacity of regulating cancer development [3]. The interplay between the sponsor immune system, malignant cells, and all other components of tumoral stroma determine proliferation, invasion, AMG 579 angiogenesis, and remodelling of extracellular matrix and metastasis. == 2. Cellular Microenvironment and Hematopoiesis == Lymphoid neoplasms are functionally connected tissues dependent on the microenvironment, determining morphology and tumor classification, medical behaviour, prognosis, and immune response to the tumor [4]. Maybe one of the greatest exponents of the maxim that tumors constitute caricatures of normal tissues from which they arise might be the lymphoproliferative syndromes. In physiological conditions, the production of cellular elements corresponding to the immune system is an elaborated process, into which a series of main cells evolve inside a sequential way, in a process of differentiation of each of the hematopoietic series. Its shortcomings are implied in the pathogenesis.